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Abstract 
The availability of reliable and fast analytical method is crucial for the quality control of multi-API in a single 
dosage form. Herein, two methods have been developed and validated for the determination of Cyproheptadine 
hydrochloride (CH), Thiamine mononitrate (Vit. B1), Calcium pantothenate (Vit. B5) and Pyridoxine hydrochloride 
(Vit. B6) in uncoated tablets. To assay the vitamins, a mobile phase combination of Phosphate buffer pH 3.5 and 
Methanol in the ratio 93:7, using Eurospher ODS (150 x 4.5mm) as the stationary phase with a flow rate set at 1.0 
mL/min at ambient temperature conditions was adopted. Wavelength of detection was 270 nm with a run time of 
0.00 to 5.50 minutes for Thiamine mononitrate and Pyridoxine hydrochloride, and 205 nm from 5.50 to 11.00 
minutes for Calcium pantothenate. A good resolution and a short run time of 11 minutes were achieved with the 
validated conditions. The retention times of Thiamine mononitrate, Pyridoxine hydrochloride and Calcium 
pantothenate were 2.823±0.020, 4.184±0.007 and 10.025±0.015 respectively. 
The mobile phase for Cyproheptadine HCl was methanol and an ion-pairing solution (70:30), set at a flow rate of 
1mL/min, a runtime of 8 minutes, an injection volume of 20 µL and a wavelength of 285 nm using Eurospher ODS 
(150 x 4.5 mm) as the stationary phase. The retention time for Cyproheptadine HCl was 4.961±0.006. Both 
methods were found to be specific, robust, accurate and precise over the concentration ranges of 0.0192 mg/mL–
0.0288 mg/mL for Thiamine mononitrate, 0.0128–0.0192 mg/mL for Pyridoxine hydrochloride, 0.032–0.048 
mg/mL for Calcium pantothenate and 0.032-0.048 mg/mL for Cyproheptadine hydrochloride. The Correlation 
Coefficient (r2) for Cyproheptadine hydrochloride, Thiamine mononitrate, Pyridoxine hydrochloride and Calcium 
pantothenate were greater than 0.999.  
The purpose of this study was to develop and validate simple HPLC methods for the estimation of Cyproheptadine 
hydrochloride, Vitamins B1, B5 and B6 in combined dosage forms. The proposed methods were found to be precise, 
specific, accurate and robust for the estimation of Cyproheptadine hydrochloride, Vitamins B1, B5 and B6.    
Keywords: Cyproheptadine hydrochloride, Thiamine mononitrate, Pyridoxine hydrochloride, Calcium 
pantothenate, RP-HPLC, Validation  
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1. Introduction 
Cyproheptadine hydrochloride is the hydrochloride salt of a synthetic methyl-piperidine derivative with 
antihistaminic and anti-serotoninergic properties. Cyproheptadine competes with free histamine (HA) for binding 
at HA-receptor sites, thereby competitively antagonizing histamine stimulation of HA-receptors in the 
gastrointestinal tract, large blood vessels, and bronchial smooth muscle. This agent also competes with free 
serotonin for binding at serotonin receptor sites. Cyproheptadine exhibits anticholinergic and sedative properties 
and has been shown to stimulate appetite and weight gain. Cyproheptadine has a molecular formula of C21H22CIN 
(National Center for Biotechnology Information 2020a). Thiamine mononitrate has a molecular formula of 
C12H17N5O4S. It plays a key role in intracellular glucose metabolism and it is thought that thiamine inhibits the 
effect of glucose and insulin on arterial smooth muscle cell proliferation. Thiamine plays an important role in 
Chemistry and Materials Research                                                                                                                                                    www.iiste.org 
ISSN 2224- 3224 (Print) ISSN 2225- 0956 (Online) 
Vol.12  No.6, 2020 
 
36 
helping the body convert carbohydrates and fat into energy. It is essential for normal growth and development and 
helps to maintain proper functioning of the heart and the nervous and digestive systems (Wishart et al. 2018). 
Pyridoxine hydrochloride has a molecular formula of C8H12ClNO3. It is the hydrochloride salt form of pyridoxine, 
a water-soluble vitamin B. Pyridoxine hydrochloride is converted into the active form pyridoxal 51-phosphate 
(PLP), an essential cofactor in many enzymatic activities including synthesis of amino acids, neurotransmitters, 
and sphingolipids. This vitamin is essential to red blood cell, nervous system, and immune systems functions and 
helps maintain normal blood glucose levels (National Center for Biotechnology Information 2020b). Calcium 
pantothenate has a molecular formula of C18H32CaN2O10. It is the calcium salt of the water-soluble vitamin B5, 
ubiquitously found in plants and animal tissues with antioxidant property. Pantothenate is a component of 
coenzyme A (CoA) and a part of the vitamin B2 complex. Vitamin B5 is a growth factor and is essential for various 
metabolic functions, including the metabolism of carbohydrates, proteins, and fatty acids. This vitamin is also 
involved in the synthesis of cholesterol, lipids, neurotransmitters, steroid hormones, and hemoglobin (National 
Center for Biotechnology Information 2020c). Several chromatographic methods for the determination of 
Cyproheptadine hydrochloride, Thiamine mononitrate, Pyridoxine hydrochloride and Calcium pantothenate have 
been reported (Shino et al. 2008; Hasimoglu and Ghodke 2018; Yantih et al. 2011; Staroverov et al. 2004). The 
aim of this study is to develop simple RP-HPLC methods. This study was done in accordance with the International 
Conference on Harmonization (ICH) guidelines (Q2(R1) 2005). 
 
2. Materials and Methods 
2.1 Equipment and materials 
1-Hexanesulphonic acid sodium salt for HPLC (VWR Prolabo chemicals 10E050001), Glacial Acetic acid (BN 
CC2C620145), Acetonitrile (HPLC grade (Thermo Fisher Scientific India, PVT Ltd, 99.8%, 4353)), Syringe-
driven filter unit (Make: Millipore Millex, Lot Number: ROAAB2861), pH Meter (Make: Labinda Model: SAB 
5000), Millipore vacuum pump (Make: Millipore, Model: WP6122050), 0.2 µm Mobile phase filter (Make: 
Millipore Model: GNWP); Potassium dihydrogen orthophosphate, Phosphoric acid, Methanol (HPLC Grade 
(VWR Chemicals; 100.0%, BN 14K240503)), Distilled water, Volumetric pipettes, Knauer HPLC system with 
Autosampler and UV detection, Measuring cylinder, ODS Column (Eurospher-150 x 4.6) mm column; particle 
size 5 µm (Make: Knauer (Germany)), Analytical balance (Make: Kern and Sohn GmbH, Model: ABJ 120-4M).  
 
2.2 Instrumentation and Chromatographic conditions 
A High Performance Liquid Chromatographic (HPLC) system, controlled by Knauer Advanced Scientific 
Instrument data handling system (Knauer 2000) and coupled with an autosampler was used for the analysis. The 
data was recorded using Euro Chrome software. For the analysis of the Vitamins, a stainless steel column 150 mm 
long, 4.5 mm internal diameter filled with Octadecyl silane chemically bonded to porous silica particles of 5 µm 
diameter (Make: Knauer Advanced Scientific, Germany) was used with the mobile phase composed of Phosphate 
buffer pH 3.5 and Methanol (93:7) at ambient temperature. The mobile phase was pumped through the column at 
a flow rate of 1 mL/minute. The sample injection volume was 20 µL. The UV detector was set at a wavelength of 
270 nm from 0.00 to 5.50 minutes for the detection of Thiamine mononitrate and Pyridoxine hydrochloride, and 
205 nm from 5.50 to 11.00 minutes for the detection of Calcium pantothenate. The run time was 11 minutes. For 
Cyproheptadine, same column as for the vitamins was used. The mobile phase consisted of an ion paring reagent 
prepared separately and mixed with methanol in the ratio (30:70). The wavelength was 285 nm, injection volume 
of 20 µL, flow rate of 1mL/min and Runtime of 8 minutes. 
Model tablets containing 1.5 mg Thiamine mononitrate, 1 mg Pyridoxine hydrochloride and 2.5 mg Calcium 
pantothenate were prepared with the following excipients; Lactose, Dicalcium phosphate granules, 
Microcrystalline cellulose Avicel 12, Sodium starch glycolate, Talc, Magnesium stearate and Cab-O-sil. Samples 
were analysed using the developed RP-HPLC method. The results are reported as means ± SEM (standard error 
of the mean). Results were statistically analysed for significant differences. 
 
2.3 Preparation of solutions 
2.3.1 Analytical Solutions for Analysis of Cyproheptadine HCl 
2.3.1.1 Diluent 
Acetonitrile, Glacial Acetic acid and Water (5:1:94) 
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2.3.1.2 Preparation of Solution A 
Approximately 700 mg of 1-Hexanesulphonic acid sodium salt was weighed and transferred into a 500 mL 
volumetric flask containing 250 mL of distilled water, dissolved, added 5 mL of Glacial acetic acid and made to 
volume with distilled water. 
2.3.1.3 Preparation of Mobile phase 
Into a 500 mL volumetric flask, about 350 mL of methanol (HPLC grade) was transferred and mixed with 150 mL 
of Solution A. 
2.3.1.4 Preparation of Standard solution 
This was prepared by accurately weighing and transferring about 40 mg of Cyproheptadine HCl working standard 
into a 100 mL volumetric flask and dissolved to the mark with the diluent with intermittent shaking for 30 minutes. 
5 mL of the resultant solution was dissolved into a 50 mL volumetric flask and diluted to the mark with the diluent. 
2.3.1.5 Preparation of Sample Solution 
About 240 mg of the synthetic blend was weighed into a 100 mL volumetric flask and dissolved with the diluent 
for 30 minutes to the mark.  
2.3.2 Preparation of Analytical Solutions for Analysis of Vitamins B1, B5 and B6. 
2.3.2.1 Preparation of Buffer solution 
About 500 mg of monobasic potassium phosphate was dissolved in 1000 mL of water and adjusted with phosphoric 
acid to a pH of 3.5. 
2.3.2.2 Preparation of Mobile phase 
Into a 1000 mL volumetric flask, 900 mL of the phosphate buffer was transferred, and 100 mL of Methanol HPLC 
grade was added with thorough mixing. 
2.3.2.3 Preparation of Standard solution 
About 24 mg of Vit. B1 working standard, 40 mg of Vit. B5 working standard and 16 mg of Vit. B6 working standard 
were accurately weighed and transferred into a 100 mL volumetric flask. They were dissolved and diluted to the 
mark with distilled water. 5 mL was transferred into a 50 mL volumetric flask and diluted to the mark with distilled 
water. 
2.3.2.4 Preparation of Sample solution 
About 960 mg of the synthetic blend was weighed and transferred into a 250 mL volumetric flask. 10 mL of 
methanol was added and swirled to disperse the specimen. Distilled water was added to volume, mixed and filtered. 
 
2.4 Method Development 
In order to develop a relatively cheap chromatographic system for Vitamins B1, B5 and B6, Methanol (HPLC grade) 
was chosen as the only organic solvent during the developmental stages. In order to obtain the best resolution 
possible, various mobile phase ratios were utilized. A mobile phase ratio of Phosphate buffer pH 3.5 and Methanol 
(93:7) was found appropriate at a flow rate of 1 mL/min with wavelength of 270 nm from 0.00 to 5.50 minutes for 
the detection of Thiamine mononitrate and Pyridoxine hydrochloride, and 205 nm from 5.50 to 11.00 minutes for 
the detection of Calcium pantothenate. Eurospher ODS (150 x 4.5mm) was the column used at an injection volume 
of 20 µL and Run time of 11 minutes. Column temperature was ambient. 
The method for Cyproheptadine hydrochloride consisted of an Ion pairing reagent (1-Hexanesulphonic acid 
sodium salt) used in the mobile phase to enhance the separation of the vitamins and Cyproheptadine hydrochloride 
on the reversed phase column. A mobile phase composition of Methanol and ion paring solution (70:30) was used 
with a flow rate of 1 mL/min, runtime of 8 minutes, injection volume of 20 µL and a wavelength of 285 nm. 
 
3. Results and Discussions 
3.1 Specificity and specificity by forced degradation 
In evaluating specificity, there were no interferences. Injections of the placebo and the mobile phase (diluent) gave 
no peaks. The order of elution is as follows; Thiamine mononitrate followed by Pyridoxine hydrochloride and then 
Calcium pantothenate. 
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Table 1. Retention times of Peaks obtained from Placebo, Active ingredients and Diluent 
Solutions Retention time (minute) 
Diluent for Cyproheptadine hydrochloride No peak 
Diluent for Vitamins B1, B5 and B6 No peak 
Placebo for Cyproheptadine hydrochloride No peak 
Placebo for Vitamins B1, B5 and B6 No peak 
Synthetic blend containing Cyproheptadine hydrochloride, 
Vitamins B1, B5 and B6 (Method used for analyzing 
Cyproheptadine HCl) 
5.128 ± 0.005 
Synthetic blend containing Cyproheptadine hydrochloride, 
Vitamins B1, B5 and B6 (Method used for analyzing Vitamins B1, 
B5 and B6) 
2.823 ± 0.020; 4.184 ± 0.007; 
11.025 ± 0.015 
Cyproheptadine hydrochloride working standard solution 4.961 ± 0.006 
Thiamine mononitrate working standard solution 3.144 ± 0.004 
Pyridoxine hydrochloride working standard solution 4.233 ± 0.007 
Calcium pantothenate working standard solution 10.303 ± 0.014 
 
 
3.1.1 Representative chromatograms justifying specificity of the two methods 
        
Figure 1. Standard solution (CH)           Figure 2. Standard solution (Vitamins B1, B5 and B6) 
 
Table 2. Results obtained from thermally stressed (dry heat in oven at 80 oC for 4 hours) samples 
No. Solutions Retention time (minute) 
1 
Thermal stressed synthetic blend solution for Vitamins B1, 
B5 and B6 
Vit B1 = 2.033 min, Vit. B6 = 4.083 
min, Vit. B5 = No peak  
2 Thermal stressed placebo for Vitamins B1, B5 and B6 No peaks 
3 
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Table 3. Results of System suitability test 
Parameter CH Vit. B1 Vit. B6 Vit. B5 
Retention Time (min) 4.961±0.006 3.144±0.004 4.233±0.007 10.303±0.014 
PA (mAu*min) 63.5857±0.149 11.9722±0.075 5.0195±0.038 6.9625±0.013 
RSD of RT (min) 0.28 0.28 0.43 0.33 
RSD of PA (%) 0.57 1.54 1.83 0.44 












1.763±0.719 5.168±2.109 6.931±2.829 
 
The system was found suitable as per predetermined acceptance criterion prior to the generation of all other data 




Six sample preparations of the synthetic blend were analysed as per the protocol. The percentage contents and the % 
RSD were determined. RSD for the sample preparation of Cyproheptadine was 1.39% That of Vit. B1,Vit. B5 and 
Vit. B6 were 0.90%, 1.01% and 1.51% respectively.  
 
3.2.2 Intermediate Precision 
3.2.2.1 Inter-day Precision 
Analysis conducted on Day 1 and Day 2 were compared. For Cyproheptadine, RSD for Day 1 was 1.39% and that 
for Day 2 was 1.80%. For the Vit. B1, RSD for Day 1 was 0.90% and Day 2 was 1.53%. For Vit. B6, Day 1 was 
1.51% and Day 2 was 1.47%. For Vit. B5, Day 1 was 1.01% and Day 2 was 1.05%. Results obtained from Day 1 
and Day 2 were statistically analyzed to determine any significant differences. For acceptance of the null 
hypothesis, F-calculated is not more than F-critical value of 5.05 at 95% confidence level (Olaniyi 2005). CH gave 
an F-calculated value of 1.49. Vit. B1 was 2.66, Vit. B6 was 2.56 and Vit. B5 was 1.88. Hence, it was concluded 
that, there was no significant differences between data obtained on Day 1 and Day 2 for all the actives. 
 
3.2.2.2 Intraday Precision 
For CH, RSD for Analyst A was 1.39% and Analyst B was 1.81%. For Vit. B1, RSD for Analyst A was 0.90% and 
Analyst B was 1.40%. Vit. B6 had an RSD of 1.51% for Analyst A and 1.53% for Analyst B. For Vit. B5, Analyst 
A had 1.01% and Analyst B had 1.12%. There were no significant differences between both Analysts as CH gave 
an F-calculated value of 1.55. Vit. B1 was 2.45, Vit. B6 was 1.03 and Vit. B5 was 1.16 which were less than the F-
critical value of 5.05 at 95% confidence level. 
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3.3 Linearity and Range 
Table 4. Results of Linearity Study 
 Vit. B1 Vit. B6 Vit. B5 CH 
Concentration Range 
(mg/mL) 
0.0192 to 0.0288 0.0128 to 0.0192 0.0320 to 0.0480 0.0320 to 0.0480 
Slope 63221 17655 19991 62223 
Intercept 1.4534 2.9225 -3.5730 5.0216 
Intercept % 0.09 % 0.01 % 0.44 % 0.20 % 
Correlation coefficient 0.999580 0.999004 0.999574 0.999783 
Regression Coefficient 0.999159 0.998009 0.999148 0.999566 
 
                                       
Figure 3. Calibration curve for CH     Figure 4. Residual plot for CH 
 
   
Figure 5. Calibration Curve for Vit. B1    Figure 6. Residual plot for Vit. B1  
 
   
Figure 7. Calibration for Vit. B6    Figure 8. Residual plot for Vit. B6 
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Figure 9. Calibration curve for Vit. B5   Figure 10. Residual plot for Vit. B5 
 










Intercept 1.453429 20.28788 0.07164 0.946327 -54.8747 57.78161 
Vit. B6 
Intercept 2.922482 5.816094 0.502482 0.641731 -13.2256 19.07055 
Vit. B5 
Intercept -3.57302 10.76416 -0.33194 0.756602 -33.4591 26.31307 
CH 
Intercept 5.021553571 23.9132 0.209991 0.843937 -61.3721 71.41523 
 
Table 6. Residual output for CH and Vit. B1 
 CH Vit. B1 
Observation Predicted Y Residuals Predicted Y Residuals 
1 1996.169182 -12.0852 1215.292 -17.0041 
2 2245.062636 17.03236 1367.022 7.987114 
3 2493.956089 20.56091 1518.752 24.63629 
4 2742.849543 16.38046 1670.482 12.22346 
5 2991.742996 -36.867 1822.211 -26.3894 
6 5.021553571 -5.02155 1.453429 -1.45343 
 
Table 7. Residual output for Vit. B6 and Vit. B5 
 Vit. B6 Vit. B5 
Observation Predicted Y Residuals Predicted Y Residuals 
1 228.9095 4.517461 636.1372 -11.7652 
2 257.1579 3.101079 716.101 -9.70102 
3 285.4063 2.554696 796.0648 11.1322 
4 313.6547 2.587314 876.0286 11.02341 
5 341.9031 -9.83807 955.9924 -4.26237 
6 2.922482 -2.92248 -3.57302 3.573018 
 
From the statistical treatment of the linearity data of Cyproheptadine, the response of Cyproheptadine was linear 
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between 80.0 % to 120.0 % level. The correlation coefficient is greater than 0.998. In addition, the analysis of 
residuals shows that, the values are randomly scattered around zero, which fits, and well within the linear model. 
To evaluate whether the y-intercepts are significantly different from zero, the P-value was determined. If P value 
is > 0.05, then intercept is statistically equal to zero. For Cyproheptadine, P value is 0.843937. Hence, it is 
statistically equal to zero. In addition, the origin is within the lower and the upper limit of the 95 % confidence 
level that gives a high degree of confidence to the values obtained for intercept. Moreover, the value of the intercept 
is less than 5 % of the area response at 100 % level. 
From the statistical treatment of the linearity data of Thiamine mononitrate, Pyridoxine hydrochloride and Calcium 
pantothenate, the responses of Thiamine mononitrate, Pyridoxine hydrochloride and Calcium pantothenate were 
linear between 80.0 % to 120.0 % level. The correlation coefficients are greater than 0.998. In addition, the analysis 
of residuals shows that, the values are randomly scattered around zero, which fits, and well within the linear model. 
To evaluate whether the y-intercepts are significantly different from zero, the P-values were determined. If P value 
is > 0.05 then intercept is statistically equal to zero. For Thiamine mononitrate, Pyridoxine hydrochloride and 
Calcium pantothenate, P values were 0.946327, 0.641731 and 0.756602. Hence, it is statistically equal to zero. In 
addition, the origin is within the lower and the upper limit of the 95 % confidence level that gives a high degree 
of confidence to the values obtained for intercept. Moreover, the value of the intercept is less than 5 % of the area 
response at 100 % level. 
The Limit of Detection (LOD) and Limit of Quantitation (LOQ) were determined. For Cyproheptadine HCl, LOD 
was 0.0019 mg/mL and LOQ was 0.0058 mg/mL. Vitamin B1 had LOD of 0.0027 mg/mL and LOQ of 0.0083 
mg/mL. Vitamin B5 had LOD of 0.0014 mg/mL and LOQ of 0.0042 mg/mL. Vitamin B6 had LOD of 0.0014 
mg/mL and LOQ of 0.0043 mg/mL. 
3.4 Robustness 
Changes in flow rate (± 0.2 mL/min) and wavelength (±2) were effected to determine the robustness of the method. 
Irrespective of the changes in chromatographic conditions, all the system suitability parameters remained 
unaffected and results conformed to acceptance criteria indicating robustness of the methods. 
Table 8. Resolution factors between analytes 
 




























































Recovery studies ensures the quantification of target compounds. It is therefore very important in determining the 
accuracy of an analytical method. The percentage recoveries were found to be in the range of 98.60%-100.58% 
for CH, 98.98-100.44% for Vit. B1, 100.00-101.63% for Vit. B6 and 100.17-101.08% for Vit. B5. There were not 
significant differences between the results obtained between the various concentration levels as T-values were less 
than 4.303 at 95 % confidence level. 
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Table 9. Results from Study of Accuracy 
Vit. B1 
Level 50% 100% 50% 150% 100% 150% 
Mean % Recovery 100.44 99.45 100.44 98.98 99.45 98.98 
T-calculated 1.349 3.977 0.677 
Vit. B6 
Level 50% 100% 50% 150% 100% 150% 
Mean % Recovery 101.63 100.02 101.63 100.00 100.02 100.00 
T-calculated 1.559 3.436 0.024 
Vit. B5 
Level 50% 100% 50% 150% 100% 150% 
Mean % Recovery 100.17 101.08 100.17 100.83 101.08 100.83 
T-calculated 0.939 0.797 0.316 
CH 
Level 80% 100% 80% 120% 100% 120% 
Mean % Recovery 100.58 99.92 100.58 98.60 99.92 98.60 
T-calculated 1.031 2.908 3.531 
T-critical 4.303 at 95 % probability level 
 
3.6 Stability in Analytical Solution 
The standard and sample solutions were injected within a period of 24 hours and was concluded that, standard and 
sample solutions of Thiamine mononitrate, Pyridoxine hydrochloride and Calcium pantothenate can be assayed 
within 24 hours after preparation. 
 
4. Conclusion 
The validation of the proposed isocratic RP-HPLC methods for the estimation of Cyproheptadine hydrochloride, 
Thiamine mononitrate, Pyridoxine hydrochloride and Calcium pantothenate in model tablets were carried out as 
per ICH guidelines. The methods were found to be specific, robust, accurate and precise for the estimation of 
Cyproheptadine hydrochloride, Thiamine mononitrate, Pyridoxine hydrochloride and Calcium pantothenate in 
fixed dosage forms over the concentration ranges of 0.0192 mg/mL–0.0288 mg/mL for Thiamine mononitrate, 
0.0128–0.0192 mg/mL for Pyridoxine hydrochloride, 0.0320–0.0480 mg/mL for Calcium pantothenate and 
0.0320-0.0480 mg/mL for Cyproheptadine hydrochloride. 
Thus, the methods stand validated for the estimation of Cyproheptadine hydrochloride, Thiamine mononitrate, 
Pyridoxine hydrochloride and Calcium pantothenate in fixed dosage forms and may be used to certify in-process 
and finished products as well as employed in Stability studies.         
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